Dr. Eric Haura, MD
Dr. Eric Haura, MD is a medical oncologist in Tampa, FL and has over 30 years of experience in the medical field. He graduated from Duke University School of Medicine in 1994. He is accepting new patients and telehealth appointments.
Moffitt Magnolia Campus
12902 Usf Magnolia Dr Tampa, FL 33612Make an Appointment
At a Glance
- Area of Expertise
- Offers TelehealthThis doctor offers telehealth appointments. Call the office to schedule an appointment.
Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Haura's Reviews
Likelihood to recommend Dr. Haura
3.7
| 5 Star | 67% | 67% |
| 4 Star | 0% | 0% |
| 3 Star | 0% | 0% |
| 2 Star | 0% | 0% |
| 1 Star | 33% | 33% |
Leave a review
How was your experience with Dr. Haura?Overall Patient Satisfaction
Likelihood of recommending Dr. Haura to family and friends is 3.6666667 out of 5
About Me
care philosophy
Dr Eric Haura received his undergraduate degree in Biomedical Engineering from the Johns Hopkins University in 1990 and completed medical school at Duke University School of Medicine in 1994. He returned to Johns Hopkins and completed a residency...read morebiography
Dr. Eric Haura received his undergraduate degree in Biomedical Engineering from the Johns Hopkins University in 1990 and completed medical school at Duke University School of Medicine in 1994. He returned to Johns Hopkins and completed a residency...read moreMedical Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Clinical Fellow, Duke University Medical Center - Hematology & Oncology|research Fellow, Duke University Medical Center - Genetics
Fellowship Hospital, 2000Johns Hopkins Hospital
Internship Hospital, 1995Duke University School Of Medicine
Medical School, 1994
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkAn immunoproteomic approach to characterize the CAR interactome and signalosome*, 2019-02-12
Cell-type Specific Adaptive Signaling Responses to KRASG12Cinhibition, 2021-02-22
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer, 2010-02-28
Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring anNTRKGene Fusion, 2018-07-23
A Bayesian pick-the-winner design in a randomized phase II clinical trial, 2017-07-07
Preventing Smoking Relapse in Patients With Cancer: A Randomized Controlled Trial, 2020-09-09
The Galaxy Platform for Reproducible Affinity Proteomic Mass Spectrometry Data Analysis, 2020-12-18
Strategies for power calculations in predictive biomarker studies in survival data, 2016-09-19
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma, 2016-08-05
EGFR mediates responses to small molecule drugs targeting oncogenic fusion kinases, 2017-04-20
Managing a Large-Scale Multiomics Project: A Team Science Case Study in Proteogenomics, 2020-12-18
Proteogenomic landscape of squamous cell lung cancer, 2019-08-08
Phosphoproteomics Identifies Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors, 2012-03-29
Transforming Growth Factor ß Signaling Overcomes Dasatinib Resistance in Lung Cancer, 2014-12-11
Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to ß-lapachone, 2020-01-23
Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors, 2012-02-15
Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling, 2010-10-19
Development of a Targeted Smoking Relapse-Prevention Intervention for Cancer Patients, 2016-08-03
Focus on Breast Cancer
Locations
Moffitt Magnolia Campus
Compare Providers
Providers shown based on Dr. Haura's location and specialty. Show more Oncologists.
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.